Amgen announces Artificial Intelligence (AI) Partnership with Mila

MONTREAL, March 16, 2021 /CNW/ - Amgen announced today that it has entered into a multi-year partnership with Mila – Quebec Artificial Intelligence Institute. One of the world's leading biotechnology companies, Amgen uses cutting-edge science and technology to discover and develop innovative therapeutics, and AI is currently deployed in several of its R&D and manufacturing activities. This new partnership will permit Amgen to expand its knowledge of AI and deep learning by interacting and engaging with experts in Mila's unique ecosystem, both virtually and (eventually) on the Mila campus in Montreal. This announcement was made during Effervescence 2021, an international virtual gathering of scientists, entrepreneurs and industry professionals from the life sciences and health technology sectors in the presence of the Quebec Minister of Economy and Innovation, Pierre Fitzgibbon. "We are very happy to have signed this partnership with Mila," said Philip Tagari, Amgen's Vice President of Research, Therapeutic Discovery.